Macrophage Activation Syndrome | CHOP Research Institute
 

Macrophage Activation Syndrome

Published on
May 24, 2024
In this week’s news, our researchers have developed the first-of-its-kind bone marrow atlas and innovative, painless wound dressings. Read on to learn more.

The Behrens Lab is interested in the pathogenesis and treatment of cytokine storm syndromes, including the hemophagocytic syndromes Hemophagocytic Lymphohistiocytosis (HLH) and Macrophage Activation Syndrome (MAS).  These are uniquely pediatric immunologic conditions that result in severe systemic inflammation and death if unrecognized and

Dr. Behrens' research focuses on the pathogenesis and treatment of cytokine storm syndromes, including the hemophagocytic syndromes Hemophagocytic Lymphohistiocytosis (HLH) and Macrophage Activation Syndrome (MAS).

E-mail:
behrens [at] chop.edu
Published on
Mar 2, 2018
Pilot grants from PennCHOP Microbiome Program allow investigators to find sometimes friends and sometimes foe in our microbiome.